New England Research & Management, Inc. Edwards Lifesciences Corp Transaction History

New England Research & Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 15, 2021	SELL	$83.84 - $104.76 $316,915 - $395,992	-3,780 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$57.54 - $76.95 $145,000 - $193,914	2,520 Added 200.0%	3,780 $261,000
Q1 2020 Jun 15, 2020	BUY	$52.41 - $81.0 $66,036 - $102,060	1,260 New	1,260 $238,000
Q3 2019 Nov 04, 2019	SELL	$61.55 - $75.43 $107,712 - $132,002	-1,750 Closed	0 $0
Q2 2019 Jul 09, 2019	BUY	$55.74 - $64.41 $97,545 - $112,717	1,750 New	1,750 $323,000
Q4 2018 Jan 11, 2019	SELL	$46.41 - $56.94 $201,883 - $247,689	-4,350 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$45.7 - $58.03 $198,795 - $252,430	4,350 New	4,350 $757,000
Q4 2017 Jan 09, 2018	SELL	$33.79 - $39.39 $113,196 - $131,956	-3,350 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$36.29 - $38.83 $121,571 - $130,080	3,350	3,350 $366,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.